1938P Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial

Authors :: Andrea Berghold
Gerald Höfler
Samantha Perakis
Stephan W Jahn
G. Pregartner
Thomas Bauernhofer
Armin Gerger
Ellen Heitzer
Martin Pichler
F. Posch
Herbert Stöger
L. Scheipner
Karl Kashofer
M. Speicher
K. Groller
Jakob M. Riedl
Source :: Annals of Oncology. 31:S1095-S1096
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Hematology
Cancer Treatment Trial
chemistry.chemical_compound
chemistry
Internal medicine
medicine
In patient
Refractory Carcinoma
business
DNA

Full Text Access

Tools